{"id":"NCT02267135","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Subcutaneous Secukinumab in Adults With Moderate to Severe Scalp Psoriasis","officialTitle":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Demonstrate the Efficacy of Subcutaneous Secukinumab [300 mg] as Assessed by the Psoriasis Scalp Severity Index (PSSI) at 12 Weeks of Treatment, Compared to Placebo, and to Assess Safety and Tolerability up to 24 Weeks in Adult Subjects With Moderate to Severe Scalp Psoriasis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-09-29","primaryCompletion":"2015-12-07","completion":"2015-12-07","firstPosted":"2014-10-17","resultsPosted":"2018-02-28","lastUpdate":"2021-01-05"},"enrollment":102,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Scalp Psoriasis"],"interventions":[{"type":"BIOLOGICAL","name":"Secukinumab 300 mg","otherNames":["AIN457 300 mg"]},{"type":"BIOLOGICAL","name":"Placebo","otherNames":[]}],"arms":[{"label":"Secukinumab","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will assess the efficacy and safety of secukinumab compared to placebo in adult patients who have moderate to severe scalp psoriasis that is poorly controlled by current psoriasis treatments.","primaryOutcome":{"measure":"Psoriasis Scalp Severity Index 90 (PSSI 90)","timeFrame":"12 weeks","effectByArm":[{"arm":"Secukinumab","deltaMin":52.9,"sd":null},{"arm":"Placebo","deltaMin":2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":17,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["https://www.novctrd.com/ctrdweb/patientsummary/patientsummaries?patientSummaryId=38"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":51},"commonTop":["DIARRHOEA","DERMATITIS CONTACT","NASOPHARYNGITIS"]}}